GlucoTrack, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
GCTK Nasdaq 3840 glucotrack.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GlucoTrack, Inc.

Sector Update: Health Care Stocks Advance Late Afternoon - Jun 25th, 2025 2:04 pm
Top Midday Gainers - Jun 25th, 2025 12:23 pm
Sector Update: Health Care Stocks Softer Wednesday Afternoon - Jun 25th, 2025 11:44 am
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - Jun 25th, 2025 6:30 am
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - Jun 12th, 2025 7:05 am
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - Jun 4th, 2025 6:30 am
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - May 28th, 2025 6:30 am
Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - May 20th, 2025 6:30 am
Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - May 14th, 2025 3:10 pm
Glucotrack gains HREC approval for clinical study of CBGM device - May 14th, 2025 8:23 am
Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - May 13th, 2025 6:01 am
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - Apr 16th, 2025 6:00 am
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - Apr 3rd, 2025 6:01 am
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - Mar 31st, 2025 3:00 pm
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - Mar 19th, 2025 6:01 am
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member - Feb 26th, 2025 6:01 am
Glucotrack Prices $3 Million Public Offering to Fund Expansion - Feb 5th, 2025 9:52 am
Glucotrack hits trial success for direct blood measuring CGM - Feb 4th, 2025 11:44 am
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - Feb 4th, 2025 10:24 am
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - Feb 4th, 2025 6:01 am